Pharmacovigilance in the digital age: gaining insight from social media data
Pharmacovigilance is essential for protecting patient health by monitoring and managing medication-related risks. Traditional methods like spontaneous reporting systems and clinical trials are valuable for identifying adverse drug events, but face delays in data access. Social media platforms, with...
Saved in:
| Main Authors: | Fan Dong, Wenjing Guo, Jie Liu, Tucker A. Patterson, Huixiao Hong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Experimental Biology and Medicine |
| Subjects: | |
| Online Access: | https://www.ebm-journal.org/articles/10.3389/ebm.2025.10555/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Post-marketing safety surveillance of pneumococcal vaccines: a real-world pharmacovigilance study using the U.S. vaccine adverse event reporting system (VAERS) database
by: Xinkuo Zheng, et al.
Published: (2025-08-01) -
A refined set of RxNorm drug names for enhancing unstructured data analysis in drug safety surveillance
by: Wenjing Guo, et al.
Published: (2025-05-01) -
A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study
by: Mohamed Serhan, et al.
Published: (2024-12-01) -
Regulatory-required post-marketing database studies in Japan could be leveraged to assess important potential risks as well as identified risks
by: Hiroshi Yamazaki, et al.
Published: (2025-07-01) -
Real-world pharmacovigilance reports of hepatitis A inactivated and hepatitis B (recombinant) vaccine: insights from disproportionality analysis of the vaccine adverse event reporting system
by: Yuhang Zhou, et al.
Published: (2025-06-01)